BC
AZN icon

Brookfield Corp’s AstraZeneca AZN Stock Holding History

Brookfield Corp’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-122,177
Closed -$17.5M – 153
2023
Q2 		$17.5M Sell
122,177
-39,561
-24% -$5.82M 0.07% 104
2023
Q1 		$22.5M Buy
161,738
+37,680
+30% +$5.07M 0.09% 93
2022
Q4 		$16.8M Buy
124,058
+55,934
+82% +$7.01M 0.06% 114
2022
Q3 		$7.47M Buy
68,124
+4,583
+7% +$581K 0.03% 211
2022
Q2 		$8.4M Buy
+63,541
New +$8.34M 0.04% 177
2022
Q1 		– Sell
-152,507
Closed -$17.8M – 626
2021
Q4 		$17.8M Buy
152,507
+88,924
+140% +$10.5M 0.07% 89
2021
Q3 		$7.64M Buy
63,583
+21,565
+51% +$2.51M 0.03% 169
2021
Q2 		$5.03M Buy
+42,018
New +$4.61M 0.02% 215

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Brookfield Corp's AZN Position: Q3 2023 in Review

Brookfield Corp sold out of AstraZeneca (AZN) in Q3 2023, closing a stake of 122,177 shares — an estimated $17.5M sold.

Brookfield Corp first reported a position in AZN in Q2 2021 and held it in 8 quarters. The position peaked at $22.5M in Q1 2023. 1,073 funds tracked by Wall St. Rank hold AZN as of Q3 2023.

  • Brookfield Corp reported no remaining AstraZeneca position as of Q3 2023 after selling out during the quarter.
  • Brookfield Corp sold 122,177 AstraZeneca shares in Q3 2023, an estimated $17.5M.
  • Brookfield Corp first reported a position in AstraZeneca in Q2 2021 and held it in 8 quarters.
  • Brookfield Corp's AstraZeneca position peaked at $22.5M in Q1 2023.
  • 1,073 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2023.

Based on Brookfield Corp's 13F filing for Q3 2023, filed 14 Nov 2023.